Provided by Tiger Fintech (Singapore) Pte. Ltd.

Whitehawk Therapeutics, Inc.

1.51
-0.0300-1.95%
Post-market: 1.48-0.0266-1.76%19:00 EDT
Volume:37.02K
Turnover:56.51K
Market Cap:70.64M
PE:-0.64
High:1.57
Open:1.57
Low:1.50
Close:1.54
Loading ...

Company Profile

Company Name:
Whitehawk Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2007
Employees:
40
Office Location:
2 Headquarters Plaza,East Building,11th Floor,Morristown,New Jersey,United States
Zip Code:
07960
Fax:
- -
Introduction:
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.

Directors

Name
Position
Joseph Gardner
President, Principal Executive Officer and Director
Anupam Dalal
Director
Caley Castelein
Director
Cheryl Cohen
Director
Pravin U. Dugel
Director
Steven Prelack
Director

Shareholders

Name
Position
Joseph Gardner
President, Principal Executive Officer and Director
Kevin G. Peters
Chief Scientific Officer and acting Chief Medical Officer
Regina Marek
Vice President, Principal Financial and Accounting Officer